相关实验视频

Updated: Jun 28, 2025

Pretargeted Radioimmunotherapy Based on the Inverse Electron Demand Diels-Alder Reaction

Pretargeted Radioimmunotherapy Based on the Inverse Electron Demand Diels-Alder Reaction

Published on: January 29, 2019

埃尔德海姆-切斯特病:研究向治疗疗法与疾病结果之间的相关性

Sabrina R Wilcox¹, Samuel B Reynolds¹, Asra Z Ahmed¹

¹Division of Hematology/Oncology, Department of Internal Medicine, University of Michigan Health System, Ann Arbor, MI 48109-5368, USA.

|April 13, 2024

概括

这项关于埃尔德海姆 - 切斯特病 (ECD) 的研究发现,向治疗是常见的,大多数患者实现了部分反应或更好. 在这个多样化的患者群体中,单细胞计数与治疗结果没有显著的相关性.

科学领域:

在瘤学瘤学.
血液学血液学血液学
罕见疾病罕见疾病

背景情况:

埃尔德海姆 - 切斯特病 (ECD) 是一种罕见的非朗格汉斯细胞囊炎.
对EDD的治疗策略已经发展,结合了常规疗法和常规疗法一起的向药物.
周围血液单细胞计数在囊细胞性疾病的预后意义是正在进行的研究领域.

研究的目的:

为了追溯分析患有埃尔德海姆-切斯特病 (ECD) 的成年患者的治疗反应.
为了比较各种治疗方式的疗效,包括向治疗,常规化疗,免疫治疗,皮质类固醇,手术和辐射.
调查外周血液绝对单细胞计数与ECD中的疾病活动或治疗结果之间的潜在相关性.

主要方法:

在2002年至2022年期间诊断出ECD的20名成年患者的回顾性分析.
根据接受的治疗方法评估临床反应:化疗,免疫疗法,皮质类固醇,手术,辐射和向药物.
分析与疾病进展和治疗干预措施相关的周围血液绝对单细胞计数.

主要成果:

在20名患者中,有15名患者观察到部分反应或更好.
向治疗是最常见的模式 (11/20患者).
在单细胞计数或有关治疗的疾病结果方面没有发现统计学上显著的差异,尽管注意到了趋势.

结论:

虽然向疗法在心电病中经常被使用,但这个队列在不同的治疗方式中表现出不同的反应.
周围血液单细胞计数没有在这个异质的ECD人群中显示出与疾病结果的统计学上显著的相关性.
预计将进行进一步的分析,以探索更大或更均的ECD队列中的潜在显著差异.

关键词:

埃尔德海姆切斯特是什么意思质细胞是质细胞的一种.一个单细胞单细胞.

更多相关视频

Testing Targeted Therapies in Cancer using Structural DNA Alteration Analysis and Patient-Derived Xenografts

Testing Targeted Therapies in Cancer using Structural DNA Alteration Analysis and Patient-Derived Xenografts

Published on: July 25, 2020

Y-90 Radioembolization and PD-1 Inhibitor as Neoadjuvant Treatment in Hepatocellular Carcinoma

Y-90 Radioembolization and PD-1 Inhibitor as Neoadjuvant Treatment in Hepatocellular Carcinoma

Published on: May 24, 2024

相关概念视频

Targeted Cancer Therapies

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...

Combination Therapies and Personalized Medicine

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...

Tumor Immunotherapy

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.